PE20060478A1 - Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion - Google Patents
Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacionInfo
- Publication number
- PE20060478A1 PE20060478A1 PE2005000727A PE2005000727A PE20060478A1 PE 20060478 A1 PE20060478 A1 PE 20060478A1 PE 2005000727 A PE2005000727 A PE 2005000727A PE 2005000727 A PE2005000727 A PE 2005000727A PE 20060478 A1 PE20060478 A1 PE 20060478A1
- Authority
- PE
- Peru
- Prior art keywords
- tissue
- trifluorometoxyphenoxybenzene
- sulphonic acids
- refers
- formula
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 150000007513 acids Chemical class 0.000 title 1
- -1 ACIDS COMPOUNDS Chemical class 0.000 abstract 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 abstract 1
- 208000012659 Joint disease Diseases 0.000 abstract 1
- 206010041591 Spinal osteoarthritis Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 208000005801 spondylosis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
SE REFIERE A COMPUESTOS DE ACIDOS 4-TRIFLUOROMETOXIFENOXIBENCENO-4'-SULFONICOS DE FORMULA (I), EN DONDE X ES OH O -NH-OH; A ES UN RADICAL DE FORMULA (II), EN DONDE R4 ES UN ENLACE COVALENTE AL S DE (I); R1, R2 O R3 SON INDEPENDIENTEMENTE H, ALQUILO(C1-C6), -C(O)-O-R8, O-R8, ENTRE OTROS; O R1 Y R2 JUNTOS AL CARBONO AL QUE ESTAN UNIDOS FORMAN ARILO(C6-C14), Het DE 5 A 7 MIEMBROS, INDOLILO, ENTRE OTROS, OPCIONALMENTE SUSTITUIDOS CON G, TAL COMO FENILO, TETRAHIDROFURANILO O CICLOHEXILO. SON PREFERIDOS: 2-[4-(4-TRIFLUOROMETOXIFENOXI)BENCENOSULFONIL]-1,2,3,4-TETRAHIDRO-ISOQUINOLIN-1-HIDROXI-CARBOXAMIDA, ACIDO 5-[4-(4-TRIFLUOROMETOXIFENOXI)BENCENOSULFONIL]OCTAHIDROFURO[3,2-c]PIRIDIN-4-CARBOXILICO, ENTRE OTROS. TAMBIEN SE REFIERE A UN PROCEDIMIENTO DE PREPARACION Y UNA COMPOSICION FARMACEUTICA. ESTOS COMPUESTOS SON INHIBIDORES DE LA METALOPROTEINASA DE LA MATRIZ (MMP), POR LO QUE SON UTILES EN EL TRATAMIENTO DE TRANSTORNOS ARTICULARES DEGENERATIVOS COMO OSTEOARTROSIS, ESPONDILOSIS, TRANSTORNOS DEL TEJIDO CONJUNTIVO Y EN EL TRATAMIENTO DE INFLAMACIONES, ULCERAS, ATEROSCLEROSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004031620A DE102004031620A1 (de) | 2004-06-30 | 2004-06-30 | 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20060478A1 true PE20060478A1 (es) | 2006-06-22 |
Family
ID=34970397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005000727A PE20060478A1 (es) | 2004-06-30 | 2005-06-23 | Acidos 4-trifluorometoxifenoxibenceno-4'-sulfonicos y procedimientos para su preparacion |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US20070155778A1 (es) |
| EP (1) | EP1763515B1 (es) |
| JP (1) | JP4871273B2 (es) |
| KR (1) | KR20070026662A (es) |
| CN (1) | CN101035764A (es) |
| AR (1) | AR049557A1 (es) |
| AT (1) | ATE388940T1 (es) |
| AU (1) | AU2005259634A1 (es) |
| BR (1) | BRPI0512656A (es) |
| CA (1) | CA2572126A1 (es) |
| DE (2) | DE102004031620A1 (es) |
| DK (1) | DK1763515T3 (es) |
| ES (1) | ES2299039T3 (es) |
| IL (1) | IL179975A0 (es) |
| MX (1) | MXPA06014189A (es) |
| MY (1) | MY139236A (es) |
| PE (1) | PE20060478A1 (es) |
| PT (1) | PT1763515E (es) |
| TW (1) | TW200612943A (es) |
| UY (1) | UY28994A1 (es) |
| WO (1) | WO2006002764A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
| DE102005002500A1 (de) * | 2005-01-19 | 2006-07-27 | Sanofi-Aventis Deutschland Gmbh | Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen |
| WO2008146254A1 (en) | 2007-05-31 | 2008-12-04 | Koninklijke Philips Electronics N.V. | Fastening device for system irons |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0861236B2 (de) * | 1995-11-13 | 2006-08-16 | Sanofi-Aventis Deutschland GmbH | Cyclische und heterocyclische n-substituierte alpha-iminohydroxam- und carbonsäuren |
| EP0927161B1 (en) * | 1996-08-28 | 2002-10-16 | The Procter & Gamble Company | Substituted cyclic amine metalloprotease inhibitors |
| WO1998050348A1 (en) * | 1997-05-09 | 1998-11-12 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses |
| US6294573B1 (en) * | 1997-08-06 | 2001-09-25 | Abbott Laboratories | Reverse hydroxamate inhibitors of matrix metalloproteinases |
| WO1999025687A1 (en) * | 1997-11-14 | 1999-05-27 | G.D. Searle & Co. | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| US20010039287A1 (en) * | 1997-11-14 | 2001-11-08 | Thomas E Barta | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| US6750228B1 (en) * | 1997-11-14 | 2004-06-15 | Pharmacia Corporation | Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| DE10344936A1 (de) * | 2003-09-27 | 2005-04-21 | Aventis Pharma Gmbh | Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen |
| DE102004031850A1 (de) * | 2004-06-30 | 2006-01-26 | Sanofi-Aventis Deutschland Gmbh | Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
-
2004
- 2004-06-30 DE DE102004031620A patent/DE102004031620A1/de not_active Withdrawn
-
2005
- 2005-06-15 DK DK05750284T patent/DK1763515T3/da active
- 2005-06-15 JP JP2007518485A patent/JP4871273B2/ja not_active Expired - Fee Related
- 2005-06-15 EP EP05750284A patent/EP1763515B1/de not_active Expired - Lifetime
- 2005-06-15 MX MXPA06014189A patent/MXPA06014189A/es active IP Right Grant
- 2005-06-15 ES ES05750284T patent/ES2299039T3/es not_active Expired - Lifetime
- 2005-06-15 KR KR1020067027482A patent/KR20070026662A/ko not_active Ceased
- 2005-06-15 CA CA002572126A patent/CA2572126A1/en not_active Abandoned
- 2005-06-15 DE DE502005003219T patent/DE502005003219D1/de not_active Expired - Lifetime
- 2005-06-15 AT AT05750284T patent/ATE388940T1/de not_active IP Right Cessation
- 2005-06-15 BR BRPI0512656-8A patent/BRPI0512656A/pt not_active IP Right Cessation
- 2005-06-15 PT PT05750284T patent/PT1763515E/pt unknown
- 2005-06-15 CN CNA2005800218369A patent/CN101035764A/zh active Pending
- 2005-06-15 AU AU2005259634A patent/AU2005259634A1/en not_active Abandoned
- 2005-06-15 WO PCT/EP2005/006416 patent/WO2006002764A1/de not_active Ceased
- 2005-06-23 PE PE2005000727A patent/PE20060478A1/es not_active Application Discontinuation
- 2005-06-28 AR ARP050102660A patent/AR049557A1/es not_active Application Discontinuation
- 2005-06-28 TW TW094121522A patent/TW200612943A/zh unknown
- 2005-06-29 MY MYPI20052975A patent/MY139236A/en unknown
- 2005-06-30 UY UY28994A patent/UY28994A1/es unknown
-
2006
- 2006-12-11 IL IL179975A patent/IL179975A0/en unknown
- 2006-12-15 US US11/611,199 patent/US20070155778A1/en not_active Abandoned
-
2009
- 2009-12-21 US US12/643,162 patent/US20100099663A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20100099663A1 (en) | 2010-04-22 |
| CA2572126A1 (en) | 2006-01-12 |
| MY139236A (en) | 2009-09-30 |
| AU2005259634A1 (en) | 2006-01-12 |
| ES2299039T3 (es) | 2008-05-16 |
| IL179975A0 (en) | 2007-05-15 |
| DK1763515T3 (da) | 2008-06-16 |
| JP4871273B2 (ja) | 2012-02-08 |
| US20070155778A1 (en) | 2007-07-05 |
| KR20070026662A (ko) | 2007-03-08 |
| AR049557A1 (es) | 2006-08-16 |
| CN101035764A (zh) | 2007-09-12 |
| TW200612943A (en) | 2006-05-01 |
| EP1763515B1 (de) | 2008-03-12 |
| BRPI0512656A (pt) | 2008-04-01 |
| UY28994A1 (es) | 2006-01-31 |
| MXPA06014189A (es) | 2007-03-12 |
| ATE388940T1 (de) | 2008-03-15 |
| WO2006002764A1 (de) | 2006-01-12 |
| PT1763515E (pt) | 2008-04-07 |
| JP2008504316A (ja) | 2008-02-14 |
| DE502005003219D1 (de) | 2008-04-24 |
| DE102004031620A1 (de) | 2006-02-02 |
| EP1763515A1 (de) | 2007-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY28877A1 (es) | Compuestos de metil-aril o heteroaril-amida sustituida y composiciones | |
| DOP2006000169A (es) | Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| ECSP088965A (es) | Derivados de 2-tioxantina que actúan como inhibidores de la mpo | |
| GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
| EA201071232A1 (ru) | Триазины как ингибиторы киназы pi3 и mtor | |
| EA201170607A1 (ru) | Акриламидопроизводные, применимые как ингибиторы перехода митохондриальной проницаемости | |
| ECSP088765A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevención de diabetes | |
| CO6251209A2 (es) | Esteres ciclicos de boro y composiciones que los contienen | |
| PE20091712A1 (es) | Derivados de azetidina y ciclobutano como inhibidores de jak | |
| CO6230986A2 (es) | Compuesto de 4-piridinona y su uso para cancer | |
| BRPI0718700B8 (pt) | Heterodímeros de ácido glutâmico, e kit | |
| PE20081838A1 (es) | Derivados de ester o amida de imidazolilo como moduladores del receptor glucocorticoide | |
| NI201100081A (es) | Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa - iv para el tratamiento o prevención de diabetes. | |
| AR082968A1 (es) | Inhibidores biciclicos de notum pectinacetilesterasa y una composicion farmaceutica en base al compuesto | |
| HN2011000699A (es) | El compuesto (s)-1-({4-metil-5-[2-(2,2,2-trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il}-amida) de 2-amida del acido pirrolidin-1,2-dicarboxilico en forma libre o de sal y composiciones y composicion farmaceutica que lo contiene. | |
| AR067673A1 (es) | Derivados de 1,3 oxazinan - 2 - ona como inhibidores ciclicos de la 11 beta -hidroxiesteroide deshidrogenasa 1. composiciones farmaceuticas. | |
| PE20040450A1 (es) | Heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida como inhibidores de metaloproteinasa | |
| EA201170780A1 (ru) | Урацильные циклопропилнуклеотиды | |
| ECSP066383A (es) | Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias | |
| PE20081504A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| MA33384B1 (fr) | Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant | |
| ATE538651T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| PE20081159A1 (es) | Inhibidores de las quinasas y metodos para su utilizacion | |
| PE20081837A1 (es) | Derivados de quinuclinidol como antagonistas de los receptores muscarinicos | |
| MA39043A1 (fr) | Dérivés de purine substitués en positions 2 et 6, et leur utilisation dans le traitement des désordres prolifératifs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |